Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (281) 281
life sciences & biomedicine (266) 266
humans (196) 196
hepatocellular carcinoma (170) 170
male (152) 152
female (148) 148
middle aged (138) 138
adult (108) 108
aged (105) 105
gastroenterology & hepatology (77) 77
oncology (70) 70
chemistry (68) 68
metallurgy (68) 68
liver cancer (62) 62
prognosis (59) 59
retrospective studies (54) 54
biological and medical sciences (53) 53
treatment outcome (52) 52
cancer (51) 51
microbiology (50) 50
carcinoma, hepatocellular - mortality (48) 48
aged, 80 and over (46) 46
liver neoplasms - mortality (46) 46
medical sciences (46) 46
tumors (46) 46
analysis (45) 45
electricity (44) 44
biochemistry (42) 42
beer (41) 41
enzymology (41) 41
mutation or genetic engineering (41) 41
physics (41) 41
spirits (41) 41
survival (41) 41
vinegar (41) 41
wine (41) 41
liver neoplasms - pathology (40) 40
carcinoma, hepatocellular - pathology (39) 39
culture media (39) 39
basic electric elements (38) 38
compositions thereof (38) 38
microorganisms or enzymes (38) 38
propagating, preserving or maintaining microorganisms (38) 38
hepatoma (37) 37
sorafenib (37) 37
carcinoma, hepatocellular - therapy (35) 35
liver neoplasms - therapy (35) 35
gastroenterology. liver. pancreas. abdomen (33) 33
human necessities (32) 32
performing operations (32) 32
transporting (32) 32
liver. biliary tract. portal circulation. exocrine pancreas (30) 30
survival rate (30) 30
radiology, nuclear medicine & medical imaging (29) 29
risk factors (29) 29
care and treatment (28) 28
agriculture (26) 26
cell biology (26) 26
neoplasm staging (26) 26
plant sciences (25) 25
carcinoma, hepatocellular - drug therapy (24) 24
liver neoplasms - drug therapy (24) 24
original (24) 24
electric solid state devices not otherwise provided for (23) 23
semiconductor devices (23) 23
carcinoma (22) 22
follow-up studies (22) 22
liver neoplasms - diagnosis (22) 22
antineoplastic agents - therapeutic use (21) 21
carcinoma, hepatocellular - diagnosis (21) 21
original article (21) 21
surgery (21) 21
blasting (20) 20
digestive system diseases (20) 20
heating (20) 20
lighting (20) 20
mechanical engineering (20) 20
radiotherapy (20) 20
weapons (20) 20
young adult (20) 20
biotechnology & applied microbiology (19) 19
forestry (19) 19
organic chemistry (19) 19
내과학 (19) 19
animal husbandry (18) 18
diagnosis (18) 18
disease-free survival (18) 18
fishing (18) 18
general & internal medicine (18) 18
hepatocellular (18) 18
hunting (18) 18
life sciences (18) 18
medicine, general & internal (18) 18
new plants or processes for obtaining them (18) 18
patients (18) 18
plant reproduction by tissue culture techniques (18) 18
republic of korea (18) 18
research (18) 18
trapping (18) 18
antineoplastic agents (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (651) 651
Korean (450) 450
French (27) 27
German (7) 7
Japanese (6) 6
Chinese (4) 4
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
by Park, Joong‐Won and Chen, Minshan and Colombo, Massimo and Roberts, Lewis R and Schwartz, Myron and Chen, Pei‐Jer and Kudo, Masatoshi and Johnson, Philip and Wagner, Samuel and Orsini, Lucinda S and Sherman, Morris
Liver international, ISSN 1478-3223, 09/2015, Volume 35, Issue 9, pp. 2155 - 2166
epidemiology | risk factors | treatment patterns | liver cancer | disease management | global trends | observational study | Liver cancer | Observational study | Global trends | Disease management | Treatment patterns | Epidemiology | Risk factors | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Ethanol - administration & dosage | Catheter Ablation | Male | Liver Neoplasms - therapy | Embolization, Therapeutic | Liver Neoplasms - mortality | Hepatitis B - complications | Adult | Female | Hepatitis C - complications | Retrospective Studies | Liver Neoplasms - virology | Risk Factors | Europe - epidemiology | Carcinoma, Hepatocellular - virology | Asia - epidemiology | Survival Analysis | Aged | Carcinoma, Hepatocellular - therapy | Disease Management | North America - epidemiology | Longitudinal Studies | Ablation (Surgery) | Carcinoma | Liver | Hepatitis C virus | Hepatitis C | Health aspects | Cancer | Index Medicus | Liver Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The role of hepatic resection in the treatment of hepatocellular cancer
by Roayaie, Sasan and Jibara, Ghalib and Tabrizian, Parissa and Park, Joong‐Won and Yang, Jijin and Yan, Lunan and Schwartz, Myron and Han, Guohong and Izzo, Francesco and Chen, Mishan and Blanc, Jean‐Frédéric and Johnson, Philip and Kudo, Masatoshi and Roberts, Lewis R and Sherman, Morris
Hepatology (Baltimore, Md.), ISSN 0270-9139, 08/2015, Volume 62, Issue 2, pp. 440 - 451
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Multivariate Analysis | Carcinoma, Hepatocellular - mortality | Confidence Intervals | Follow-Up Studies | United States | Humans | Middle Aged | Male | Hepatectomy - mortality | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Patient Selection | Neoplasm Recurrence, Local - pathology | Neoplasm Invasiveness - pathology | Statistics, Nonparametric | Adult | Female | Retrospective Studies | Hepatectomy - methods | Risk Assessment | Carcinoma, Hepatocellular - diagnosis | Proportional Hazards Models | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Disease-Free Survival | Liver Neoplasms - diagnosis | Survival Analysis | Aged | Neoplasm Staging | Cohort Studies | Hypertension | Liver cancer | Multivariate analysis | Liver cirrhosis | Mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Epidemiology of liver cancer in South Korea
by Kim, Bo Hyun and Park, Joong-Won
Clinical and molecular hepatology, ISSN 2287-2728, 03/2018, Volume 24, Issue 1, pp. 1 - 9
Liver cancer | Hepatocellular carcinoma | Prevalence | Epidemiology | Incidence | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Hepatocellular - epidemiology | Carcinoma, Hepatocellular - mortality | Age Factors | Carcinoma, Hepatocellular - diagnosis | Humans | Survival Rate | Liver Neoplasms - mortality | Hepatitis - complications | Liver Neoplasms - epidemiology | Hepatitis - diagnosis | Liver Neoplasms - diagnosis | Republic of Korea - epidemiology | Index Medicus | Review | 내과학
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
by Bridgewater, John and Galle, Peter R and Khan, Shahid A and Llovet, Josep M and Park, Joong-Won and Patel, Tushar and Pawlik, Timothy M and Gores, Gregory J
Journal of hepatology, ISSN 0168-8278, 2014, Volume 60, Issue 6, pp. 1268 - 1289
Gastroenterology and Hepatology | Practice guidelines | Diagnosis and management | Intrahepatic cholangiocarcinoma | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Evidence-Based Medicine - standards | Bile Duct Neoplasms - diagnosis | Bile Duct Neoplasms - epidemiology | Bile Duct Neoplasms - therapy | Cholangiocarcinoma - therapy | Cholangiocarcinoma - diagnosis | Global Health | Gastroenterology - standards | Cholangiocarcinoma - epidemiology | Humans | Bile Ducts, Intrahepatic | Practice Guidelines as Topic | Practice guidelines (Medicine) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
by Kudo, Masatoshi and Finn, Richard S and Qin, Shukui and Han, Kwang-Hyub and Ikeda, Kenji and Piscaglia, Fabio and Baron, Ari and Park, Joong-Won and Han, Guohong and Jassem, Jacek and Blanc, Jean Frederic and Vogel, Arndt and Komov, Dmitry and Evans, T R Jeffry and Lopez, Carlos and Dutcus, Corina and Guo, Matthew and Saito, Kenichi and Kraljevic, Silvija and Tamai, Toshiyuki and Ren, Min and Cheng, Ann-Lii
The Lancet (British edition), ISSN 0140-6736, 03/2018, Volume 391, Issue 10126, pp. 1163 - 1173
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Liver Neoplasms - drug therapy | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Male | Survival Rate | Treatment Outcome | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Carcinoma, Hepatocellular - drug therapy | Sorafenib | Female | Aged | Quinolines - therapeutic use | Disease | Liver | Clinical trials | Hepatocellular carcinoma | Cancer therapies | Disease control | Survival | Evidence-based medicine | Studies | Liver cancer | Chemotherapy | Hepatology | Questionnaires | Response rates | Fatalities | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
by Abou-Alfa, Ghassan K and Meyer, Tim and Cheng, Ann-Lii and El-Khoueiry, Anthony B and Rimassa, Lorenza and Ryoo, Baek-Yeol and Cicin, Irfan and Merle, Philippe and Chen, YenHsun and Park, Joong-Won and Blanc, Jean-Frederic and Bolondi, Luigi and Klümpen, Heinz-Josef and Chan, Stephen L and Zagonel, Vittorina and Pressiani, Tiziana and Ryu, Min-Hee and Venook, Alan P and Hessel, Colin and Borgman-Hagey, Anne E and Schwab, Gisela and Kelley, Robin K
The New England journal of medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 1, pp. 54 - 63
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anilides - therapeutic use | Double-Blind Method | Anilides - adverse effects | Humans | Middle Aged | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Male | Antineoplastic Agents - therapeutic use | Disease-Free Survival | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Aged | Pyridines - therapeutic use | Tyrosine | Diarrhea | Hepatocellular carcinoma | Fatigue | Oncology | Growth factor receptors | Patients | Cancer therapies | Survival | Vascular endothelial growth factor receptors | Axl protein | Liver cancer | Hepatitis | Hospitals | Collaboration | Medical prognosis | Aspartate aminotransferase | Vascular endothelial growth factor | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
by Philip J. Johnson and Shukui Qin and Joong-Won Park and Ronnie T.P. Poon and Jean-Luc Raoul and Philip A. Philip and Chih-Hung Hsu and Tsung-Hui Hu and Jeong Heo and Jianming Xu and Ligong Lu and Yee Chao and Eveline Boucher and Kwang-Hyub Han and Seung-Woon Paik and Jorge Robles-Aviña and Masatoshi Kudo and Lunan Yan and Abhasnee Sobhonslidsuk and Dmitry Komov and Thomas Decaens and Won-Young Tak and Long-Bin Jeng and David Liu and Rana Ezzeddine and Ian Walters and Ann-Lii Cheng
Journal of clinical oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 28, pp. 3517 - 3524
Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Alanine - therapeutic use | Prognosis | Follow-Up Studies | Triazines - therapeutic use | Humans | Middle Aged | Male | Liver Neoplasms - mortality | Young Adult | Alanine - analogs & derivatives | Carcinoma, Hepatocellular - drug therapy | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Double-Blind Method | Liver Neoplasms - drug therapy | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Survival Rate | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Objective Response by mRECIST as a Predictor and Potential Surrogate End Point of Overall Survival in Advanced HCC
by Lencioni, Riccardo and Montal, Robert and Torres, Ferran and Park, Joong-Won and Decaens, Thomas and Raoul, Jean-Luc and Kudo, Masatoshi and Chang, Charissa and Ríos, José and Boige, Valerie and Assenat, Eric and Kang, Yoon-Koo and Lim, Ho-Yeong and Walters, Ian and Llovet, Josep M
Journal of hepatology, ISSN 0168-8278, 2017, Volume 66, Issue 6, pp. 1166 - 1172
Gastroenterology and Hepatology | Carcinoma, hepatocellular | Liver cancer | Response evaluation criteria in solid tumours | Objective response | Brivanib, mRECIST | Advanced BCLC | Surrogate end-point | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Hepatocellular - mortality | Alanine - therapeutic use | Prognosis | Double-Blind Method | Triazines - therapeutic use | Humans | Middle Aged | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Male | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Young Adult | Alanine - analogs & derivatives | Carcinoma, Hepatocellular - drug therapy | Carcinoma, Hepatocellular - pathology | Aged, 80 and over | Biomarkers | Adult | Female | Liver Neoplasms - pathology | Aged | Hepatocellular carcinoma | Solid tumors | Medical diagnosis | Survival | Patients | Tumors | Index Medicus | Assaigs clínics | Clinical trials | Càncer de fetge | Pronòstic mèdic | Life Sciences | Human health and pathology | Hépatology and Gastroenterology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights